Magnetic resonance imaging to identify classic and nonclassic forms of ferroportin disease

Antonello Pietrangelo1, Elena Corradini, Francesca Ferrara

  • 1Center for Hemochromatosis, Department of Internal Medicine, University Hospital of Modena and Reggio Emilia, Policlinico, Via del Pozzo 71 41100 Modena, Italy. pietrangelo.antonello@unimo.it

Insights

Two forms of ferroportin-related disorder, a hereditary iron overload condition, have been identified using MRI. This non-invasive tool helps diagnose and manage the disease by assessing iron levels in spleen and bone macrophages.

Area of Science:

  • Biochemistry
  • Genetics
  • Radiology

Background:

  • Ferroportin-related disorder is an emerging cause of hereditary iron overload.
  • In vitro studies suggested potential for distinct human disease forms based on ferroportin mutations.

Purpose of the Study:

  • To investigate in vivo if different ferroportin mutations lead to distinct clinical forms of hereditary iron overload.
  • To utilize MRI for differentiating these potential disease forms.

Main Methods:

  • Magnetic Resonance Imaging (MRI) was employed to assess iron status in 22 patients from four pedigrees with distinct ferroportin mutations (A77D, N144H, G80S, Val 162del).
  • Iron content in hepatocytes, splenic macrophages, and bone marrow macrophages was evaluated.

Main Results:

  • Two distinct forms were identified: a classic form (A77D, G80S, Val 162del mutations) with iron retention in liver, spleen, and bone marrow macrophages; and a non-classic form (N144H mutation) with liver iron overload but normal spleen and bone marrow iron.
  • These forms are hypothesized to result from loss-of-function and gain-of-function mutations, respectively.
  • In treated classic form patients, spleen and spine iron accumulation persisted even with normal serum ferritin and low liver iron.

Conclusions:

  • MRI is a valuable non-invasive tool for diagnosing and categorizing ferroportin-related disorders.
  • MRI aids in monitoring iron depletion status and provides insights into disease natural history and management.
  • Distinct clinical presentations correlate with specific ferroportin mutations, suggesting different pathomechanisms.